Procter & Gamble Hygiene and Health Care Limited (BOM:500459)
India
· Delayed Price · Currency is INR | Market Cap | 368.58B |
| Revenue (ttm) | 43.41B |
| Net Income (ttm) | 8.59B |
| Shares Out | 32.46M |
| EPS (ttm) | 264.77 |
| PE Ratio | 42.89 |
| Forward PE | 38.92 |
| Dividend | 235.00 (2.07%) |
| Ex-Dividend Date | Feb 5, 2026 |
| Volume | 977 |
| Average Volume | 427 |
| Open | 11,003 |
| Previous Close | 11,355 |
| Day's Range | 11,002 - 11,365 |
| 52-Week Range | 11,212 - 14,537 |
| Beta | 0.08 |
| RSI | 25.45 |
| Earnings Date | May 26, 2026 |
About BOM:500459
Procter & Gamble Hygiene and Health Care Limited manufactures and sells branded packaged fast-moving consumer goods in the feminine care and healthcare businesses in India and internationally. It operates through Health care Products and Hygiene Products segments. The company offers health care products, including ointments and creams, cough drops, and tablets; and hygiene products, such as feminine hygiene and other skin care hygiene products, as well as feminine care pads. It also provides baby care products comprising nappies, pants, and bab... [Read more]
Financial Performance
In fiscal year 2025, BOM:500459's revenue was 43.06 billion, an increase of 2.39% compared to the previous year's 42.06 billion. Earnings were 7.18 billion, an increase of 6.32%.
Financial StatementsNews
Cautiously optimistic on growth: P&G
India Business News: NEW DELHI: Procter & Gamble Hygiene and Health Care on Thursday said it is cautiously optimistic on growth as FMCG trends continue to evolve and c.
Procter & Gamble Q3 FY25 Results: Revenue up 9.68% YoY to Rs 1247.63 crore, Net profit rises 17.33% YoY
Procter & Gamble Hygiene and Health Care Limited reported a strong financial performance for the quarter ended December 31, 2024 (Q3 FY25). The company achieved notable growth in both revenue and net ...
P&G Q2 Results: Revenue at Rs 1,132.73 crore, down 0.2% YoY; Net profit at Rs 211.9 crore, up 0.6% YoY
Procter & Gamble Hygiene and Health Care Limited has released its Q2 FY25 financial results, with a slight year-over-year decline in revenue and a stable growth in net profit. The company reported rev...